An intensive study of the behavior of the mesenteric circulation in relation to previously undescribed humoral substances has provided a unique challenge to our physiological concepts of peripheral vascular homeostasis. The regular appearance of the vasoactive principles VEM and VDM in the blood during particular phases of shock and hypertension, coincident with an impairment of specific inactivating systems for these substances within the kidney and liver, have been suggested (1, 2) as critical factors underlying the progressive derangement of the systemic circulation in these conditions. As a basic concept, it was proposed that the hepatorenal factors, VEM and VDM,
An intensive study of the behavior of the mesenteric circulation in relation to previously undescribed humoral substances has provided a unique challenge to our physiological concepts of peripheral vascular homeostasis. The regular appearance of the vasoactive principles VEM and VDM in the blood during particular phases of shock and hypertension, coincident with an impairment of specific inactivating systems for these substances within the kidney and liver, have been suggested (1, 2) as critical factors underlying the progressive derangement of the systemic circulation in these conditions. As a basic concept, it was proposed that the hepatorenal factors, VEM and VDM, represent constituents of a general homeostatic mechanism essential for effective regulation of blood flow within the tissue proper (2) .
The implied relationship of these principles to systemic phenomena, such as blood pressure, compensatory vasoconstriction, and overall vascular reactivity, has been contested in view of the failure of different investigators to influence these processes, either by the acute and chronic administration of ferritin-"VDM" (3) (4) (5) , or by surgical extirpation of the kidneys (6, 7) . In the case of human bioassay data (8, 9) , the question has been raised whether we are dealing with biochemical processes, causally related to concurrent circulatory disturbances, or with a relationship secondary to local vascular changes developing in different organs out of an imbalance in the systemic circulation.
The current report represents an experimental appraisal of the proposed physiological implica1This investigation was supported in part by a research grant (H-1244) from the National Heart Institute, of the National Institutes of Health, United States Public Health Service, and a grant from the Life Insurance Medical Research Fund.
tions of blood-borne agents identified by the rat mesoappendix procedure. Special consideration was given to VEM and VDM in relation to particular systemic functions, such as blood pressure, vasoconstriction, vasodilation, and the development of abnormal circulatory conditions.
MATERIALS AND METHODS
The rat mesoappendix bioassay is based upon the detection of alterations in the constrictor response of the arteriolar elements of the terminal vascular bed to topically applied epinephrine following the intravenous administration of aliquots of blood or tissue extracts. Details of the method and its biological implications have been published elsewhere (10, 11) . The least concentration of epinephrine, sufficient to produce contraction of the precapillaries and to bring to a halt the blood flow in the capillary bed proper, is referred to as the threshold concentration (E.T.C.). The intravenous administration of biologically active agents shifts the response to epinephrine, either in the direction of increased reactivity or potentiation (eP), or causes the vessels to become refractory to epinephrine, an inhibitory (eI) reaction. Shifts in vascular reactivity are estimated by comparing the concentration of epinephrine required to elicit the threshold response at the newly established level with that of the control E.T.C. value. In addition, a record is made of the period of time during which the reaction change persisted in the test rat. The bioassay has been shown to be sufficiently accurate to permit identification of exceptionally low concentrations of eI or eP substances in biological specimens under different experimental conditions (12) . The quantitative implications of the method have, however, been found to be limited.
In the present investigation, blood samples or other vasoactive materials were introduced for bioassay in doses of 0.5 ml. per 150 gm. rat. The crystalline ferritin used was prepared from horse spleen and purified according to the method of Mazur and Shorr (13) . Renal VEM was prepared by incubating fresh slices of rat kidney for 45 minutes under anaerobic conditions at 37.5°C. in the Warburg bath, using a proportion of 1 gram of tissue to 5 parts of Ringer-phosphate solution.
EXPERIMENTAL FINDINGS
A. Independence of blood-borne vasoactivsity and systemic blood pressure Two sets of experiments were conducted in order to determline whether eI and eP substances bear more than a temporal relation to fluctuations in the systemic blood pressure; in one, the question was explored as to the extent to which the local constrictor reaction to epinephrine was influenced by agents which elevate or lower blood pressure; and in the second, the reverse situation was examined, the effect of humorally mediated eP or eI reactions on the blood pressure level.
1. Pressor-depressor agents: In the initial studies, equivalent hyper-and hypotensive excursions were instituted acutely by a series of pressor or depressor agents in rats in which the cecal mesentery had been exposed for microscopic examination. The findings summarized in graph form in Figure 1 (2) angiotonin, 1.5 p.u., (3) 1-arterenol, 2.5Z g., (4) barium chloride, 0.1 mg., (5) Neo-SynephrineO, 0.25 mg., (6) PitressinO, .001 p.u., (7) PitressinO, .01 p.u., (8) kidney VEM, 0.5 ml., (9) KG, 5 mg., (10) adenylic acid, 0.3 mg., (11) serotonin, 0.2 mg., (12) Paredrine4b, 0.5 mg., (13) histamine, 0.25 mg., (14) Priscoline@, 0.2 mg., (15) sodium nitrite, 0.1 mg., (16) Benodaine(3 (piperoxane HG), 0.4 mg., (17) Mecholyl, 2 pg., (18) ferritin, .002 pg., (19) liver VDM, 0.5 ml., (20) In experimental shock, Page (14) has shown that the overall vascular reactivity, as determined by the systemic pressor response to a series of test agents, was depressed during the terminal stages of the shock syndrome. This stage corresponds with the period during which our observations (15) indicated hyporeactivity to topical epinephrine in the mesoappendix and omentum of shocked animals. The two independent sets of observations suggested that the hyporeactive behavior of the vessels to systemic and to local influences might be a reflection of the same vascular defect. The vasoconstrictor drugs tested systemically by Page during shock in dogs were applied topically to the surface of the mesentery in four rats subjected to hemorrhagic shock (1 hour at 50 mm. Hg followed by 2 hours at 35 mm. Hg). Although the vessels showed an eI reaction, they were not refractory to topically applied angiotonin or PitressinO9. In a series of 10 animals, ferritin (in a range of from 0.1 to .001 pg. per ml. at a rate of 1 ml.
per hour) had no significant effect on blood pressure. A representative protocol of this group is shown in Figure 2a . Continuous infusion for two hours of VDM, prepared by in sitro anaerobic incubation of liver tissue, likewise did not alter the blood pressure. Blood samples, removed at intervals for bioassay throughout these experiments, showed positive titers of vasoactivity, indicating that effective blood levels had been maintained by the infusion procedure.
Similar infusion experiments with renal VEM in six animals showed no pressor action ( Figure  2b ). Negative effects on blood pressure were also obtained with infusions of VEM and VDM in three animals which had been nephrectomized, and in four eviscerated rats (liver and gastrointestinal tract removed according to procedure of Engel, Harrison, and Long [16] ). This procedure ruled out the influence of the kidney and liver in suppressing any possible systemic action of the eP and eI agents.
Direct microscopic visualization was also carried out to ascertain whether the prolonged administration of an eI substance, ferritin, would continue to depress the constrictor response to epinephrine throughout the period of infusion. In eight experiments of this type, a wide range of concentrations (.001 to .25 pg. per ml.) were used, including doses which in single injections in assay experiments uniformly elicited an eI reaction. Despite the infusion of ferritin for periods up to 120 minutes, it was not possible to maintain the vascular response to epinephrine at hyporeactive levels by this means for more than 20 to 25 minutes. In the infusion experiment illustrated in Figure 2a , a concentration of ferritin of .015 pAg. per ml. elicited an initial short period of hyporeactivity, which was followed by a prominent phase of hyperreactivity until, at the end of 30 to 40 minutes, the E.T.C. in the mesentery. had increased from 1:2 million to 1: 30 million. The biphasic pattern of response with ferritin was obtained both with the intravenous and intra-arterial routes of administration. Such infusions resulted in augmented responses not only in the capillary bed proper, but in five of the eight animals caused a hyperreactive condition in the large vessels up to and including small arteries (100 to 200 micra in diameter) and muscular venules (150 to 250 micra in diameter). This type of response was highly atypical, since in the conventional bioassay experiment the acute administration of vasoactive agents led to changes manifest chiefly in the metarterioles and precapillaries.
Ferritin, in addition to its vasoactive properties, has been reported to stimulate the release of the antidiuretic hormone (A.D.H.) from the pituitary (17) . The pbssibility was investigated that the secondary period of hyperreactivity with protracted administration of ferritin might be related to the release of the A.D.H. which, in turn, increased vascular reactivity. However, opposite types of reactions were obtained when low (.01 pug. per ml.) and high (.1 pg. per ml.) concentrations of ferritin were infused into acutely nephrectomized and/or adrenalectomized animals, as well as in hypophysectomized rats (a series of three rats was studied in each of these experimental categories).
Continuous administration of kidney VEM, was carried out in six normal rats at three concentration levels-the original incubation supernatant, at half dilution, and at one quarter dilution with saline. A similar pattern of response was observed with each of these concentrations. As in the standard bioassay procedure, an eP change in vascular reactivity developed, which however did not persist and became less evident after 35 to 40 minutes despite continued infusion of VEM for another 60 to 90 minutes (see Figure 2b) Table III , the incidence of positive eP and eI activity in the blood of hypertensives was no greater than that in several different diseases, not associated with abnormal blood pressure.
2. Shock: In the present re-evaluation of the role of VEM and VDM in the genesis of hemorrhagic shock, an attempt was made to obtain direct evidence for a humoral contribution to the vascular sequelae of shock by infusing during the two major phases of the syndrome the oppositely acting humoral component. Thus, during the initial compensatory stage, liver VDM, or ferritin was infused, while during the terminal decompensatory phase, kidney VEM was given. In these experiments, rats anesthetized with sodium pentobarbital were subjected to graded hemorrhage while connected to a bleed-out reservoir which could be elevated or lowered to maintain the blood pressure at a desired level. Infusion of vasoactive material was delivered in a volume of 0.5 ml. over a period of 60 minutes to avoid the effects of alterations in blood volume per se. Ferritin in several concentrations, .001, .01, .1, and 1.0 ug. per ml., was infused into four animals. Four rats were also tested with freshly prepared liver VDM and kidney VEM in full strength and at half dilution. As controls, aerobic preparations of liver and kidney incubates were infused under identical conditions into four animals. These materials did not exhibit vasoactive properties, as measured by the mesoappendix bioassay test.
It was anticipated that liver VDM or ferritin, introduced during the early phase of active compensation in shock, might counteract the characteristic patterns of vascular hyperreactivity in the mesentery. As indicated by a representative protocol in Figure 3 , this did not occur. The vascular bed during this stage (1 hour post 2.5 per cent blood loss, blood pressure 65 mm. Hg) was highly ischemic, and hyperreactive (twenty times). No relaxation of precapillary vasoconstriction, or opening up of "inactive" capillaries was observed, despite the fact that with the infusion of 0.1 ug. per ml. of ferritin, blood specimens showed an eI ef-fect in test rats. Since vascular hyperreactivity was not abolished, this led to a situation where a preponderance of blood-borne VDM (ferritin) existed in conjunction with an eP status in the mesentery proper.
In a comparable series of experiments on six rats, the infusion of kidney VEM during the latter stage of shock (3 hours post 3.5 to 4.0 per cent blood loss, blood pressure 35 mm. Hg) failed to produce a salutary effect on either the sluggish blood flow in the capillary bed, or on the hyporeactive state of the metarterioles and precapillaries. A typical example of the VEM infusion studies is shown in Figure 3 . Actually, the infusion of aerobic kidney incubates, which did not possess eP activity, brought about a definite improvement in capillary blood flow. The beneficial effect was transient however and the capillary flow reverted to its stagnant state almost immediately following cessation of a 60-minute infusion.
Our earlier studies (2, 15) had indicated that the irreversible stage of hemorrhagic shock was associated with the appearance of VDM in the bloodstream. Exceptions to this have recently been encountered with experiments where hemorrhagic shock was induced in eviscerated animals (23) . Bioassays of the blood were carried out in six such experiments. In these animals the entire intestinal tract up to the diaphragm, was surgically removed and the hepatic veins leading from the liver were then ligated. The kidneys were left in situ. This type of operative procedure was carried out with essentially no frank loss of blood, so that the blood pressure postoperatively remained within normal limits. Hemorrhagic hypotension (40 mm. Hg after 3 per cent blood loss) resulted within 2 to 2% hours in a state of shock which was completely refractory to blood replacement therapy. The blood of such animals contained no demonstrable vasodepressor material as evidenced by rat bioassay experiments.
Whether or not this type of circulatory collapse can be compared directly with that which occurs in the intact animal is, of course, open to question. However, the experiments do indicate that irreversibility can be induced in the absence of both the liver and the intestinal tract which, in the normal animal subjected to shock, appear to be the major sites of vascular decompensation and sequestration of blood from the active circulation.
3. Identification of hepatic VDM: Various independent methods have been employed with a view toward identifying the particular agent responsible for the vasoactivity of selected test samples. The premise that the eI activity of blood and tissue samples was referable to a single principle, ferritin (VDM), is based upon immunochemical inactivation of the biological effects of such samples by specific antibodies to ferritin (13) . Evidence that ferritin was not the only vasoinhibitor which appeared in the blood and tissues during stress was provided by fractionation experiments effected.
An important issue in this regard was the extent to which changes in the constrictor response of the mesenteric circulation to topical epinephrine could be construed to indicate a comparable tendency (potentiation or inhibition) in other functional reactions. Here an unpredictable situation was encountered. In terms of vascular caliber, both eP and eI humoral activity developed independently of a tendency towards vasoconstriction and vasodilation. Ancillary experiments showed the presence of an increased sensitivity to epinephrine in adrenalectomized rats during a period when the vessels show a loss of tone and dilate (25) , and the development, with adrenergic blocling drugs, of a refractory state to epinephrine concurrent with vasoconstriction (26) . These findings emphasize the uncertainty of relying upon E.T.C. alone as an index of peripheral vascular dysfunction.
The claim has been advanced that vasoexcitatory agents other than VEM exert their vascular effect on the mesenteric bed indirectly through an action on the kidney and the secondary release of VEM. In support of this thesis, Shorr and Baez (18) cited experiments in arenal animals in which they found a definite impairment' of the usual epinephrine potentiation, evoked by vasoactive materials, such as I-arterenol and renin in normal rats. These observations were made in rats several hours after occlusion of the renal circulation by traction on exteriorized ligatures around the kidney pedicle. On the other hand, in our studies, acute renal occlusion had no comparable attenuating effect on the response of the terminal bed to potentiating agents. Renal occlusion, in both sets of experiments, eliminated the kidneys as a possible source of humoral material for the ensuing vascular reaction. Yet in acute situations (up to two hours in the present experiments), the injection of vasoactive agents led to a typical excitatory shift in the response to topical epinephrine. Such evidence indicated that the eP effect in these experiments could not be ascribed to the secondary release of renal VEM. A possible explanation, for the differences between acutely nephrectomized animals and those in which the kidneys were removed several hours earlier, would be the gradual loss with time of some agent, continuously secreted under aerobic conditions by the normal kidneys, necessary to sustain the capacity to respond to stimulating agents. These hypothetical agents would apparently differ from VEM which is not present in the blood under normal circumstances and has been found to be elaborated by the kidney only during stress, or under conditions of reduced circulation or hypoxia.
It has been postulated in hypertension and congestive heart failure that the chronic action of eP and eI principles on the terminal vascular bed disrupts local blood flow to the extent that systemic readjustments at abnormal levels become necessary to compensate for these derangements. The appearance of VEM and VDM in regular sequence during the development of renal hypertension in dogs and rats (22) represents the major support for this thesis. Since recent investigations of the biological implications of the rat bioassay method indicate that quantitative estimates of the titer of circulating material could not be achieved (19) , a direct relation between these vasoactive principles and the progressive elevation of blood pressure cannot be established at present. The circumstantial nature of the evidence had made it difficult to ascertain whether the renal and hepatic principles appear during hypertension antecedent to changes in blood pressure, or whether they develop in these tissues subsequent to an increased arteriolar tone of unknown origin.
The bioassay experiments on the blood of patients with hypertension and other hospital patients must be taken into consideration in this regard. The demonstration of both VEM and VDM in the blood of patients suffering from a variety of diseases, irrespective of the level of their blood pressure, is not compatible with a causal relationship of these agents to abnormal blood pressure states. It would rather appear that the elaboration of eI and eP principles and their entrance into the bloodstream may represent a nonspecific sequel of an altered tissue blood flow which develops during various stress or disease conditions. Recent investigations have suggested the existence of a variety of eI and eP substances in different experimental situations (19) . It was concluded that the primary function of such humoral vasoactive agents was the intrinsic regulation of the circulation within their tissues of origin, rather than the systemic importance previously attached to such agents (2) because of their appearance in the bloodstream under different conditions. Within a considerable range, the opening and closing of precapillary sphincters and terminal arterioles constitute purely local, self-limiting phenomena concerned with the redistribution of blood in accord with tissue needs. Inasmuch as humoral vasoactive factors of the type under discussion function primarily within this sphere, it has been difficult to implicate them directly in systemic disturbances. Still problematical is the extent to which vasoactive metabolites serve a function other than that of local hormones in their particular organ of genesis. SUMMARY 1. It has not been possible to establish a consistent relationship between the development of vasoexcitatory (eP) or vasoinhibitory (eI) effects in the mesentery and the degree of vasoconstriction or vasodilation which accompanies the reaction.
2. Continuous intravenous or intra-arterial infusion of kidney VEM, liver VDM or ferritin has no sustained effect on blood pressure, or the subsequent pressor response to vasoconstrictor drugs. 3 . Evidence is presented to indicate that VEM and VDM probably constitute only one facet of a multiplicity of biological agents affecting the behavior of the terminal vascular bed.
Vasoexcitatory and vasoinhibitory agents
were shown to be present in the blood of 90 patients selected at random, irrespective of demon-strable vascular disease or the precise level of the blood pressure.
5. It is concluded that the sequential relationship of blood-borne epinephrine potentiating (eP) and inhibitory (eI) substances to particular systemic phenomena cannot be established on the basis of the evidence at present available.
